Trials / Completed
CompletedNCT02854644
Study of the Anti-tumoral Immune Response
Study of the Anti-tumoral Immune Response T Cells Cluster of Differentiation 4 (TCD4): Proof of the Concept in Breast Cancer and Glioma
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 167 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Besancon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the frequency of the spontaneous T cells specific CD4 answers of tumoral antigens breast cancer and glioma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | additional blood sample |
Timeline
- Start date
- 2014-01-27
- Primary completion
- 2021-10-27
- Completion
- 2021-10-27
- First posted
- 2016-08-03
- Last updated
- 2022-06-01
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02854644. Inclusion in this directory is not an endorsement.